Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Duncan J. Topliss, Gerasimos Filippatos et al.|Diabetes Care|2022

Cited by 207